← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2009-03-16

Drug application

FDA Application #

ANDA090433

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

ALKEM LABS LTD

First approval

2009-03-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown